AMGEN INC Operating Cash Flow 2007-2025 | AMGN
Beta
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is AMGEN INC's current operating cash flow?
AMGEN INC (AMGN) annual operating cash flow for 2025 was $9.96B, a 13.33% decline from 2024. AMGEN INC operating cash flow for the quarter ending December 31, 2025 was $1.60B.
What was AMGEN INC's operating cash flow in 2024?
AMGEN INC annual operating cash flow for 2024 was $11.49B, a 35.64% increase from 2023.
What was AMGEN INC's operating cash flow in 2023?
AMGEN INC annual operating cash flow for 2023 was $8.47B, a 12.86% decline from 2022.
What is AMGEN INC's 5-year operating cash flow CAGR?
AMGEN INC operating cash flow grew at a compound annual growth rate (CAGR) of 1.05% from FY2020 to FY2025, going from $10.50B to $9.96B over 5 years.
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-1.0%
FY2020
$10.50B
→
FY2025
$9.96B
07080910111213141516171819202122232425
5 years selected
Operating Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.96B | -13.3% | 10-K |
| FY2024 | $11.49B | +35.6% | 10-K |
| FY2023 | $8.47B | -12.9% | 10-K |
| FY2022 | $9.72B | +5.0% | 10-K |
| FY2021 | $9.26B | -11.8% | 10-K |
| FY2020 | $10.50B | +14.7% | 10-K |
| FY2019 | $9.15B | -19.0% | 10-K |
| FY2018 | $11.30B | +1.1% | 10-K |
| FY2017 | $11.18B | +7.9% | 10-K |
| FY2016 | $10.35B | +6.4% | 10-K |
| FY2015 | $9.73B | +8.7% | 10-K |
| FY2014 | $8.95B | +42.3% | 10-K |
| FY2013 | $6.29B | +7.0% | 10-K |
| FY2012 | $5.88B | +14.9% | 10-K |
| FY2011 | $5.12B | -11.5% | 10-K |
| FY2010 | $5.79B | -8.7% | 10-K |
| FY2009 | $6.34B | +5.8% | 10-K |
| FY2008 | $5.99B | +10.9% | 10-K |
| FY2007 | $5.40B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →